Cherrydale Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860K Buy
717
+1
+0.1% +$1.02K 0.22% 34
2026
Q1
$658K Sell
716
-16
-2% -$16.2K 0.2% 39
2025
Q4
$786K Hold
732
0.24% 35
2025
Q3
$558K Sell
732
-23
-3% -$17.1K 0.18% 41
2025
Q2
$588K Buy
755
+20
+3% +$15.5K 0.2% 39
2025
Q1
$607K Sell
735
-6
-0.8% -$4.99K 0.24% 35
2024
Q4
$572K Buy
741
+3
+0.4% +$2.48K 0.22% 35
2024
Q3
$654K Buy
738
+1
+0.1% +$899 0.27% 32
2024
Q2
$667K Buy
737
+67
+10% +$53.6K 0.29% 30
2024
Q1
$521K Buy
670
+93
+16% +$66.2K 0.24% 33
2023
Q4
$336K Buy
577
+26
+5% +$15.2K 0.18% 35
2023
Q3
$296K Buy
551
+25
+5% +$12.9K 0.18% 35
2023
Q2
$247K Buy
+526
New +$221K 0.17% 34

Other funds holding LLY

Cherrydale Wealth Management's LLY Position: Q2 2026 in Review

Cherrydale Wealth Management increased its Eli Lilly (LLY) stake by 0.14% in Q2 2026, buying an estimated $1.02K and bringing the position to 717 shares worth $860K. The position accounts for 0.22% of the portfolio, ranked #34.

Cherrydale Wealth Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cherrydale Wealth Management held 717 shares of Eli Lilly worth $860K as of Q2 2026.
  • Cherrydale Wealth Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.22% of Cherrydale Wealth Management's portfolio in Q2 2026, its #34 holding.
  • Cherrydale Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cherrydale Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.